Safeguarding Sample Integrity in Antibody Workflows

Improper handling and storage of antibodies can compromise sample integrity, performance, and reliability as a result of aggregation and chemical instabilities, aka physicochemical changes. Temperature excursions and repeated freeze–thaw cycles promote aggregation and denaturation, degrading functional binding over time. Light exposure and oxidative stress modify liability-prone amino acid residues such as methionine and tryptophan, lowering activity and altering analytical results. Adsorption to container and process interfaces (e.g., glass, plastics, air–liquid or oil–water interfaces) reduces effective concentration and can seed aggregation, introducing variability. Collectively, these effects erode yield, potency, and reproducibility and can manifest as assay drift compromising the test accuracy and reliability.

By contrast, primary packaging that maintains sample integrity through temperature,, light, leaching, and atmosphere changes helps preserve antibody stability and minimizes losses from aggregation, denaturation, and activity decline.

How Storage Containers Shape Sample Integrity

Packaging Leechables

After the upstream process, the container closure system (CCS) becomes the antibody’s environment impacting sample integrity during storage and transport. Material options include plastic and glass each with application benefits and challenges. Plastic primary packaging, while chemically inert and durable, can release organic leachables that interact with proteins, so early screening of plastics is a recommended part of contact chemistry risk assessment validations. Considerations for Type I glass include surface treatments and fill volumes that can change extractables profiles over time.

Surface Chemistry Matters

Antibodies do not only sit in solution; they meet container walls where contact adsorption can deplete effective concentration and seed particles. This phenomenon is demonstrated in several highly cited studies involving glass microparticles showing near-monolayer, largely irreversible adsorption by multiple mAbs. More recent studies demonstrate that tuning the silanol (Si-OH) density of glass surfaces can measurably change, as a result of surface hydrophilicity, likelihood to interact with proteins, and mAb stability under mechanical stress, reinforcing early findings and need to perform stability studies.

Light Exposure is a Controllable Risk

Therapeutic antibodies undergo photodegradation under visible light, especially blue wavelengths around 400–500 nm, so containers and handling that minimize transmission in this band help preserve antibody stability. Polypropylene (PP) containers block most UV light below 300nm making mAbs but may pose risks for photodegradation when exposed to higher nm ranges of sunlight, fluorescent, and certain LED lights. Pharmacopoeial guidance can be found in USP General Chapter <671>defining requirements for light-resistant containers (e.g., amber glass), both percent transmission and nm range, offering a practical path to mitigation.

Container Additives Can Drive Instability

Finally, features beyond the base material can matter. In formats such as prefilled syringes, silicone oil used for lubrication has been linked to higher particulate levels and aggregation risk, underscoring the need to evaluate coatings and additives alongside the container material itself. In addition, the same material, coating, and additive considerations should be given to the closure materials in direct contact with the antibodies.

Taken together, these factors: leachables, surface interactions, light, and additives, are the through-line from container choice to sample integrity.

Container choices that protect antibody stability

Selecting container and closure systems that counter these mechanisms helps maintain antibody stability from clinical to fill and finish through long term commercial storage. Examples include low extractable borosilicate glass and polypropylene, PTFE faced silicone liners and stoppers, amber vessels for light sensitive formulations, and cold storage validated leak proof CCS ensuring long term storage stability. The products listed next illustrate how specific glassware and accessories can serve as controls within this strategy. Final selection should be confirmed with compatibility testing and stability studies appropriate to the formulation and workflow.

Implementing a container strategy for sample integrity

A practical path starts with defining the critical quality attributes for the antibody and the likely stressors across the workflow. Map exposure to interfaces, temperature excursions, light, and handling from fill and finish through storage and transport. Shortlist container and closure options that counter those risks.

Recommended next step

DWK can help translate your application and material performance requirements into a qualified container and closure system solution meeting sample integrity objectives. Sample materials and components are available to support stability evaluations.